Insider · CIK 0001055530
Steven Girgenti
Files at BIAF (bioAffinity Technologies, Inc.). First filing -, latest -.
Steven Girgenti files SEC Form 4 as chair and director at BIAF (bioAffinity Technologies, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Steven Girgenti has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 10, 2025 | BIAF bioAffinity Technologies, Inc. | AGrant or award Common Stock | +14,814 | $0.00 | $0 | 1,080,062 | Jan 14, 2025 |
Questions about Steven Girgenti
Answered from the filings on this page, as of the latest one.
Is Steven Girgenti buying or selling?
Steven Girgenti has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Steven Girgenti's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Steven Girgenti has 0.
Where does Steven Girgenti file Form 4?
Steven Girgenti has filed Form 4 at BIAF (bioAffinity Technologies, Inc.) as Executive Chairman. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.